Table of Contents

• What Are Neurobehavioral Research Peptides?
• Which Compounds Are Available in the True Peptide Labs Neurobehavioral Category?
• What Are the Categories of Neurobehavioral Research Peptides?
• Which Neurobehavioral Research Peptides Are Most Studied?
• What Is the Importance of Neurobehavioral Research Peptides in Preclinical Science?
• What Research Protocols Are Described in the Neurobehavioral Peptide Literature?
• Are Neurobehavioral Research Peptides Studied in Combination?
• What Dose Ranges Appear in Published Neurobehavioral Peptide Studies?
• What Endpoints Are Measured in Neurobehavioral Peptide Research?
• What Receptors Do Neurobehavioral Research Peptides Target?
• What Adverse Events Have Been Reported in the Neurobehavioral Peptide Research Literature?
• In What Form Do Neurobehavioral Research Peptides Ship?
• How Are Neurobehavioral Research Peptides Tested for Purity?
• How to Purchase Neurobehavioral Research Peptides Online
• What Is the Difference Between Neurobehavioral and Cognitive Research Peptides?

What Are Neurobehavioral Research Peptides?

Neurobehavioral research peptides are synthetic peptide compounds used in laboratory studies to investigate central nervous system pathways involved in motivated behavior, reward, social recognition, arousal, and stress adaptation in animal models and in vitro neuronal systems. These compounds act at targets including the melanocortin receptor family (MC1R through MC5R), the oxytocin receptor (OXTR), the kisspeptin receptor (KISS1R/GPR54), and ACTH-derived melanocortin fragments acting at central nervous system sites. The class is defined by neuroactive mechanism and behavioral endpoint category, per the pharmacological framework described in Cone (2005) in Endocrine Reviews and subsequent reviews of neuropeptide behavioral pharmacology.

Which Compounds Are Available in the True Peptide Labs Neurobehavioral Category?

The compounds available in the True Peptide Labs neurobehavioral research category, organized by mechanism, are listed below. Each compound links to its dedicated product page with certificate of analysis, primary literature references, and lot-specific purity data.

• PT-141 (10 mg) — Cyclic heptapeptide melanocortin receptor agonist with selectivity for MC3R and MC4R, studied in the central nervous system pharmacology literature
• Melanotan II (10 mg) — Cyclic α-MSH analog acting at MC1R, MC3R, MC4R, and MC5R, studied for melanocortin receptor characterization
• Oxytocin (5 mg) — Nine-amino-acid neuropeptide, studied for social recognition, pair-bonding, and stress-response endpoints; cross-listed from the neuroendocrine category
• Kisspeptin (10 mg) — Neuropeptide encoded by the KISS1 gene, studied at the KISS1R/GPR54 receptor for HPG axis and reproductive-behavior research; cross-listed from the neuroendocrine category
• N-Acetyl Semax (10 mg) — Acetylated ACTH(4-10) heptapeptide analog, studied for dopaminergic tone and attentional endpoints; cross-listed from the cognitive category
• N-Acetyl Selank (10 mg) — Acetylated tuftsin-derived heptapeptide, studied for anxiolytic and stress-adaptation endpoints; cross-listed from the cognitive category
• DSIP (5 mg, 15 mg) — Delta sleep-inducing peptide, studied for arousal-state and sleep-architecture endpoints; cross-listed from the neuroendocrine category

Each compound ships as lyophilized powder with a lot-specific certificate of analysis. Individual product pages provide the sequence, molecular weight, purity data, and primary literature citations for that specific compound.

What Are the Categories of Neurobehavioral Research Peptides?

The categories of neurobehavioral research peptides, organized by target and mechanism, are as follows:

1. Central melanocortin receptor agonists — cyclic peptides including PT-141 and Melanotan II, studied at MC3R and MC4R as tools for probing hypothalamic melanocortin signaling and its downstream behavioral outputs.
2. α-MSH analogs — including Melanotan II, structural analogs of the endogenous α-melanocyte-stimulating hormone with broad melanocortin receptor activity.
3. Oxytocin receptor agonists — including native oxytocin, studied at the OXTR for effects on social recognition, pair-bonding paradigms, and prosocial behavior in rodent models.
4. Kisspeptin family neuropeptides — including Kisspeptin-10 and full-length isoforms, studied at KISS1R for HPG axis signaling and reproductive-behavior research.
5. ACTH-derived neuropeptide fragments — including Semax and its N-acetyl analog, derived from ACTH(4-10) and studied for dopaminergic tone, attentional performance, and behavioral activation.
6. Tuftsin-derived anxiolytic peptides — including Selank and its N-acetyl analog, studied for GABAergic signaling and stress-related behavioral endpoints.
7. Arousal-state regulators — including delta sleep-inducing peptide (DSIP), studied for effects on slow-wave sleep and arousal transitions in electrophysiological recordings.

Which Neurobehavioral Research Peptides Are Most Studied?

The neurobehavioral research peptides with the highest publication volume in PubMed include oxytocin (more than 25,000 indexed publications, with the modern behavioral-neuroscience literature accelerating after Kosfeld et al. 2005 in Nature at the University of Zurich), kisspeptin (more than 3,500 indexed publications since its identification as the ligand for GPR54), the melanocortin receptor peptide series including PT-141 and Melanotan II (with the underlying MC3R/MC4R pharmacology characterized in more than 2,000 publications), and the Semax and Selank compound series from the Institute of Molecular Genetics of the Russian Academy of Sciences. Individual product pages in this category link to the primary literature for each specific compound.

What Is the Importance of Neurobehavioral Research Peptides in Preclinical Science?

Neurobehavioral research peptides are important to preclinical science because they are the primary experimental tools for probing neuropeptide signaling in animal models of motivation, reward, social behavior, and arousal regulation. The melanocortin receptor system, characterized in the Cone laboratory at Vanderbilt University and in the 2005 Endocrine Reviews synthesis, is a central node in hypothalamic behavioral regulation, and MC3R/MC4R-selective ligands including PT-141 have served as key pharmacological tools in that literature. The kisspeptin system, identified as the ligand for GPR54 in the 2003 papers from Massachusetts General Hospital and the Institut de Génétique et de Biologie Moléculaire et Cellulaire, is the upstream regulator of GnRH release and a core target in reproductive neuroendocrinology research. Compounds in this category inform mechanism-of-action understanding for the melanocortin-behavior axis, the oxytocin-social-cognition model, and the kisspeptin-reproductive-axis framework in the peer-reviewed literature.

What Research Protocols Are Described in the Neurobehavioral Peptide Literature?

Published preclinical protocols for neurobehavioral peptides typically describe administration schedules (single-dose acute paradigms and chronic dosing over 5–21 days), routes (subcutaneous and intracerebroventricular for melanocortin compounds; intranasal for Semax and Selank; intraperitoneal and subcutaneous for kisspeptin research), and endpoint measurements specific to each compound (three-chamber social interaction test for oxytocin research, conditioned place preference for reward-pathway studies, luteinizing hormone (LH) pulse frequency for kisspeptin research, and open-field locomotor analysis for arousal endpoints). Study designs vary by research question — receptor binding assays typically use HEK293 cells transfected with the target receptor, while behavioral phenotyping requires whole-animal models. Researchers must consult peer-reviewed methodology sections and obtain approval from their institution's IACUC or IRB before designing any in vivo study, per NIH Office of Laboratory Animal Welfare guidance.

Are Neurobehavioral Research Peptides Studied in Combination?

Neurobehavioral research peptides are studied in combination in the published literature, in what pharmacology reviews term convergent-pathway or complementary-endpoint research. Semax and Selank are frequently investigated together in the Russian neuropharmacology literature for combined attentional and anxiolytic endpoints given their complementary melanocortin and GABAergic mechanisms. Melanocortin receptor ligands have been co-administered with oxytocin in social-behavior paradigms in rodent research to probe interactions between the two systems. All combination research described in the primary literature is conducted in laboratory settings under approved study protocols reviewed by the researcher's institution.

What Dose Ranges Appear in Published Neurobehavioral Peptide Studies?

Dose ranges in the published neurobehavioral peptide literature vary substantially by compound, model system, route of administration, and endpoint. Reported ranges span, for reference: 0.1–1 mg/kg subcutaneous for melanocortin receptor peptides in rodent MC4R pharmacology studies; 0.1–10 nmol intracerebroventricular for oxytocin in central social-behavior paradigms per the Neumann laboratory at the University of Regensburg; 1–10 nmol/kg subcutaneous for kisspeptin-10 in HPG axis studies; and 50–450 µg/kg intranasal for Semax in rodent attention research from the Institute of Molecular Genetics. Model systems include murine (C57BL/6J, prairie vole for pair-bonding paradigms, and knockout variants), rat (Wistar, Sprague-Dawley), and in vitro (HEK293 expressing target receptors, primary hypothalamic neuron cultures). Specific compound product pages link to the primary literature where researchers can review the exact dose ranges reported for each study. This information is provided as literature reference only and does not constitute a recommendation for use.

What Endpoints Are Measured in Neurobehavioral Peptide Research?

The endpoints measured in neurobehavioral peptide research are as follows:

1. Social recognition and interaction — quantified in three-chamber social interaction tests and partner-preference paradigms in prairie voles.
2. Motivated behavior and reward — assessed by conditioned place preference (CPP), progressive-ratio operant tasks, and intracranial self-stimulation thresholds.
3. Anxiety-related behavior — measured in elevated plus maze, open field, and light-dark box tests.
4. Arousal and locomotor activity — quantified in open-field and home-cage activity monitoring systems.
5. HPG axis activation — measured as luteinizing hormone (LH) and follicle-stimulating hormone (FSH) pulse frequency and amplitude in serial serum sampling.
6. Receptor binding affinity — quantified as Ki or IC50 in radioligand displacement assays at MC3R, MC4R, OXTR, and KISS1R.
7. c-Fos immunoreactivity — used as a marker of neuronal activation in specific hypothalamic and limbic nuclei following peptide administration.
8. Neuroendocrine hormone quantification — serum oxytocin, vasopressin, ACTH, and cortisol measured by ELISA or radioimmunoassay.

What Receptors Do Neurobehavioral Research Peptides Target?

The receptors targeted by neurobehavioral research peptides in this category are as follows:

1. Melanocortin-3 receptor (MC3R) — G-protein-coupled receptor expressed in the hypothalamic arcuate nucleus and limbic regions, targeted by PT-141 and Melanotan II.
2. Melanocortin-4 receptor (MC4R) — G-protein-coupled receptor expressed throughout the paraventricular nucleus and brainstem, a primary target of PT-141 and Melanotan II.
3. Melanocortin-1 receptor (MC1R) — targeted by α-MSH analogs including Melanotan II.
4. Oxytocin receptor (OXTR) — targeted by oxytocin, coupled to Gq/PLC signaling in central and peripheral sites.
5. Kisspeptin receptor (KISS1R / GPR54) — targeted by kisspeptin isoforms, expressed on GnRH neurons in the hypothalamus.
6. ACTH(4-10) melanocortin fragment binding sites — targeted by Semax and its N-acetyl analog.
7. DSIP binding sites — target characterization remains an active area of the neuropeptide literature.

What Adverse Events Have Been Reported in the Neurobehavioral Peptide Research Literature?

The adverse events reported in the published preclinical and clinical trial literature for neurobehavioral research peptides include injection-site observations (erythema, transient inflammation) for parenteral administration, nasal mucosal effects for intranasal routes, and, for compounds with human clinical research such as oxytocin and central melanocortin peptides, dose-dependent effects documented in the trial safety data submitted to regulatory agencies. Melanocortin receptor peptides in particular have documented dose-related observations in the published clinical research record, and researchers must review the complete published safety data — including FDA Advisory Committee briefing documents where applicable — for any specific compound before designing a study. Some studies have found variable event rates that may be partly due to differences in formulation, route, and titration schedule across trials.

In What Form Do Neurobehavioral Research Peptides Ship?

Neurobehavioral research peptides from True Peptide Labs ship as lyophilized (freeze-dried) peptide powder in sealed sterile vials, packaged with a lot-specific certificate of analysis (COA) documenting purity by HPLC and mass by MS. Unopened vials are typically stored refrigerated at 2–8°C per the storage instructions on the COA, and reconstituted material is stored per the published stability data for the specific compound. Cold-pack shipping options are available for temperature-sensitive compounds. All orders ship from the True Peptide Labs facility in Palm Beach Gardens, Florida.

How Are Neurobehavioral Research Peptides Tested for Purity?

Neurobehavioral research peptides at True Peptide Labs are tested every lot by third-party ISO-accredited analytical laboratories using high-performance liquid chromatography (HPLC) for purity determination and mass spectrometry (MS) for molecular weight confirmation. Certificates of analysis are lot-specific and are available on each product page or by request. Testing methodology follows the analytical standards described in the United States Pharmacopeia (USP) general chapter <1503> for peptide characterization.

How to Purchase Neurobehavioral Research Peptides Online

Neurobehavioral research peptides can be purchased directly through the True Peptide Labs catalog on this page. Products are sold exclusively for research use by qualified researchers, laboratories, and institutions, and are not available for human use. All orders ship from the Palm Beach Gardens, Florida facility with standard shipping and cold-pack options for temperature-sensitive compounds. By purchasing, buyers affirm the material will not be administered to humans or animals outside of an approved research protocol reviewed by their institution's IACUC or IRB.

What Is the Difference Between Neurobehavioral and Cognitive Research Peptides?

Neurobehavioral research peptides target central nervous system pathways involved in motivated behavior, reward, social recognition, and arousal — including the melanocortin, oxytocin, and kisspeptin systems — while cognitive research peptides target pathways involved in attention, memory consolidation, and neuroplasticity, including the BDNF/TrkB axis and GABAergic signaling. The two categories overlap for compounds such as Semax, Selank, and oxytocin, which have both cognitive-domain and behavioral-domain endpoints in the published literature. The dedicated cognitive research peptides category page covers Semax, Selank, Pinealon, and VIP under their primary attention-and-memory framework, and the neuroendocrine research peptides category page covers oxytocin, kisspeptin, and DSIP under their primary hypothalamic-pituitary framework.